Basic Stats
| CIK | 1328790 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to China Medicine Corporation
SEC Filings (Chronological Order)
This page provides a complete, chronological list of SEC Filings, excluding ownership filings which we provide elsewhere.
| January 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 333-133283 CHINA MEDICINE CORPORATION (Exact name of registrant as specifie |
|
| December 21, 2012 |
As filed with the Securities and Exchange Commission on December 21, 2012 Registration No. |
|
| December 21, 2012 |
As filed with the Securities and Exchange Commission on December 21, 2012 Registration No. |
|
| October 4, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-51379 CHINA MEDICINE CORPORATION (Exact name of registrant as specified |
|
| September 27, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 26, 2012 CHINA MEDICINE CORPORATION (Exact name of Registrant as specified in Charter) Nevada 000-51379 51-0539830 (State or other Jurisdiction (Commission File Number) (IRS |
|
| September 18, 2012 |
CHME / China Medicine Corp. / OEP CHME Holdings, LLC - SCHEDULE 13D/A Activist Investment SC 13D/A 1 oep13da091212.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* China Medicine Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 000-51379 (CUSIP Number) OEP CHME Holdings, LLC OEP CHME Holdings, LLC Dechert LLP c/o One Eq |
|
| September 18, 2012 |
Exhibit 1 ESCROW AGREEMENT THIS ESCROW AGREEMENT (as the same may be amended or modified from time to time and including any and all written instructions given to the Escrow Agent (hereinafter defined) pursuant hereto, this “Agreement”) is made and entered into as at May 16, 2011, by and among OEP CHME Holdings, LLC, a Delaware limited liability company (“OEP”, “Party A”), China Medicine Corporation, a Nevada corporation (“Company”, “Party B”, and together with Party A, sometimes referred to individually as a “Party” or collectively as the “Parties”), and JPMorgan Chase Bank, N. |
|
| September 18, 2012 |
Exhibit 3 ESCROW AGREEMENT THIS ESCROW AGREEMENT (as the same may be amended or modified from time to time and including any and all written instructions given to Escrow Agent (hereinafter defined) pursuant hereto, this “Agreement”) is made and entered into as at January 31, 2012, by and among OEP CHME Holdings, LLC, a Delaware limited liability company (“OEP”, “Party A”), Guangzhou Konzern Medicine Co. |
|
| September 18, 2012 |
Exhibit 2 ESCROW FUNDS LOAN AGREEMENT THIS ESCROW FUNDS LOAN AGREEMENT (this “Agreement”) is made and entered as of March 2, 2012 by and between OEP CHME Holdings, LLC, a Delaware limited liability company (“OEP”) and China Medicine Corporation, a Nevada corporation (the “CHME”). |
|
| September 13, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 7, 2012 CHINA MEDICINE CORPORATION (Exact name of Registrant as specified in Charter) Nevada 000-51379 51-0539830 (State or other Jurisdiction of Incorporation) (Commission |
|
| August 3, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): July 30, 2012 CHINA MEDICINE CORPORATION (Exact name of Registrant as specified in Charter) Nevada 000-51379 51-0539830 (State or other Jurisdiction (Commission File Number) (IRS Empl |
|
| April 2, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC File Number: 000-51379 CUSIP Number: 169491107 (Check one): þ Form 10-K o Form 20-F o Form 11-K ¨ Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: December 31, 2011 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ T |
